Mexico has agreements with two Chinese companies and one American company for vaccine trials, Mexican Foreign Minister Marcelo Ebrard said during Tuesday morning’s news conference.
Mexico will be participating in trials of vaccines being developed by Janssen Pharmaceuticals (owned by Johnson & Johnson) and Chinese companies Cansino Biologics Inc and Walvax Biotechnology Co Ltd, bringing the number of vaccine trials in the country to four.
"We have agreements with three different companies, one from the US and two from China; it's called a memorandum of understanding, the goal is that the protocols for phase three will take place in Mexico. After this announcement, Mexico will participate in four protocols from September to January," Ebrard said.
In July, Ebrard announced Mexico will participate in phase three of a Covid-19 vaccine trial from the French pharmaceutical company Sanofi-Pasteur's Mexico branch.